2018 Vol.36, N°1 - Table of contents
January-February 2018
One year in review
CER11111
2018,36,1
Pg. 0001-0014
Free to view
One year in review 2017: spondyloarthritis
R. Terenzi, S. Monti, G. Tesei, L. Carli
R. Terenzi, S. Monti, G. Tesei, L. Carli
Full Papers
CER10392
2018,36,1
Pg. 0015-0020
Free to view
Gout in Duke Federico of Montefeltro (1422-1482): a new pearl of the Italian Renaissance
A. Fornaciari, V. Giuffra, E. Armocida, D. Caramella, F.J. Rühli, F.M. Galassi
A. Fornaciari, V. Giuffra, E. Armocida, D. Caramella, F.J. Rühli, F.M. Galassi
CER9988
2018,36,1
Pg. 0021-0028
Free to view
Rheumatologists’ guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback
N. Lesuis, R.F. Van Vollenhoven, R.P. Akkermans, L.M. Verhoef, M.E. Hulscher, A.A. Den Broeder
N. Lesuis, R.F. Van Vollenhoven, R.P. Akkermans, L.M. Verhoef, M.E. Hulscher, A.A. Den Broeder
CER10149
2018,36,1
Pg. 0029-0035
Free to view
Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice
L. Leon, A. Gomez, C. Vadillo, E. Pato, L. Rodriguez-Rodriguez, J.A. Jover, L. Abasolo
L. Leon, A. Gomez, C. Vadillo, E. Pato, L. Rodriguez-Rodriguez, J.A. Jover, L. Abasolo
CER10071
2018,36,1
Pg. 0036-0043
Free to view
IFN-γ, CXCL16, uPAR: potential biomarkers for systemic lupus erythematosus
S. Wen, F. He, X. Zhu, S. Yuan, H. Liu, L. Sun
S. Wen, F. He, X. Zhu, S. Yuan, H. Liu, L. Sun
CER10244
2018,36,1
Pg. 0044-0049
Free to view
Timing of onset affects arthritis presentation pattern in antisyntethase syndrome
M.A. González-Gay, C. Montecucco, A. Selva-O’callaghan, E. Trallero-Araguas, O. Molberg, H. Andersson, J. Rojas-Serrano, D.I. Perez-Roman, J. Bauhammer, C. Fiehn, R. Neri, S. Barsotti, H.M. Lorenz, A. Doria, A. Ghirardello, F. Iannone, M. Giannini, F. Franceschini, I. Cavazzana, K. Triantafyllias, M. Benucci, M. Infantino, M. Manfredi, F. Conti, A. Schwarting, G. Sebastiani, A. Iuliano, G. Emmi, E. Silvestri, M. Govoni, C.A. Scirè, F. Furini, F.J. Lopez-Longo, J. Martínez-Barrio, M. Sebastiani, A. Manfredi, J. Bachiller-Corral, W.A. Sifuentes Giraldo, M.A. Cimmino, C. Cosso, A. Belotti Masserini, G. Cagnotto, V. Codullo, M. Romano, G. Paolazzi, R. Pellerito, L.A. Saketkoo, N. Ortego-Centeno, L. Quartuccio, A. Batticciotto, E. Bartoloni Bocci, R. Gerli, C. Specker, E. Bravi, C. Selmi, S. Parisi, F. Salaffi, F. Meloni, E. Marchioni, A. Pesci, G. Dei, M. Confalonieri, P. Tomietto, L. Nuno, F. Bonella, N. Pipitone, A. Mera-Valera, N. Perez-Gomez, S. Gerzeli, R. Lopez-Mejias, C.J. Matos-Costa, J.A. Pereira Da Silva, J. Cifrian, C. Alpini, I. Olivieri, M.Á. Blázquez Cañamero, A.B. Rodriguez Cambrón, S. Castañeda, L. Cavagna
on behalf of AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.
M.A. González-Gay, C. Montecucco, A. Selva-O’callaghan, E. Trallero-Araguas, O. Molberg, H. Andersson, J. Rojas-Serrano, D.I. Perez-Roman, J. Bauhammer, C. Fiehn, R. Neri, S. Barsotti, H.M. Lorenz, A. Doria, A. Ghirardello, F. Iannone, M. Giannini, F. Franceschini, I. Cavazzana, K. Triantafyllias, M. Benucci, M. Infantino, M. Manfredi, F. Conti, A. Schwarting, G. Sebastiani, A. Iuliano, G. Emmi, E. Silvestri, M. Govoni, C.A. Scirè, F. Furini, F.J. Lopez-Longo, J. Martínez-Barrio, M. Sebastiani, A. Manfredi, J. Bachiller-Corral, W.A. Sifuentes Giraldo, M.A. Cimmino, C. Cosso, A. Belotti Masserini, G. Cagnotto, V. Codullo, M. Romano, G. Paolazzi, R. Pellerito, L.A. Saketkoo, N. Ortego-Centeno, L. Quartuccio, A. Batticciotto, E. Bartoloni Bocci, R. Gerli, C. Specker, E. Bravi, C. Selmi, S. Parisi, F. Salaffi, F. Meloni, E. Marchioni, A. Pesci, G. Dei, M. Confalonieri, P. Tomietto, L. Nuno, F. Bonella, N. Pipitone, A. Mera-Valera, N. Perez-Gomez, S. Gerzeli, R. Lopez-Mejias, C.J. Matos-Costa, J.A. Pereira Da Silva, J. Cifrian, C. Alpini, I. Olivieri, M.Á. Blázquez Cañamero, A.B. Rodriguez Cambrón, S. Castañeda, L. Cavagna
on behalf of AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group.
CER10351
2018,36,1
Pg. 0050-0055
Free to view
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial
X. Baraliakos, A.J. Kivitz, A.A. Deodhar, J. Braun, J.C. Wei, E.M. Delicha, Z. Talloczy, B. Porter
for the MEASURE 1 Study Group
X. Baraliakos, A.J. Kivitz, A.A. Deodhar, J. Braun, J.C. Wei, E.M. Delicha, Z. Talloczy, B. Porter
for the MEASURE 1 Study Group
CER10326
2018,36,1
Pg. 0056-0061
Free to view
Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker for predicting lung manifestations?
M. Kontic, L. Stojanovich, M. Mijailović-Ivković, M. Velinović, J. Srnka, M. Zdravkovic
M. Kontic, L. Stojanovich, M. Mijailović-Ivković, M. Velinović, J. Srnka, M. Zdravkovic
CER10334
2018,36,1
Pg. 0062-0072
Free to view
Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis
X. Kong, L. Ma, Z. Ji, Z. Dong, Z. Zhang, J. Hou, S. Zhang, L. Ma, L. Jiang
X. Kong, L. Ma, Z. Ji, Z. Dong, Z. Zhang, J. Hou, S. Zhang, L. Ma, L. Jiang
CER10432
2018,36,1
Pg. 0073-0080
Free to view
Cardiovascular risk stratification in axial spondyloarthritis: carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients
J. Rueda-Gotor, J. Llorca, A. Corrales, J.A. Parra, V. Portilla, F. Genre, R. Blanco, M. Agudo, P. Fuentevilla, R. Expósito, C. Mata, T. Pina, C. González-Juanatey, M.A. González-Gay
J. Rueda-Gotor, J. Llorca, A. Corrales, J.A. Parra, V. Portilla, F. Genre, R. Blanco, M. Agudo, P. Fuentevilla, R. Expósito, C. Mata, T. Pina, C. González-Juanatey, M.A. González-Gay
CER10451
2018,36,1
Pg. 0081-0087
Free to view
Chinese lupus treatment and research group (CSTAR) registry: X. family history in relation to lupus clinical and immunological manifestations
X. Leng, M. Li, X. Li, X. Zhang, S. Liu, L. Wu, L. Ma, L. Bi, X. Zuo, L. Sun, C. Huang, J. Zhao, Y. Zhao, X. Zeng
on behalf of the CSTAR group
X. Leng, M. Li, X. Li, X. Zhang, S. Liu, L. Wu, L. Ma, L. Bi, X. Zuo, L. Sun, C. Huang, J. Zhao, Y. Zhao, X. Zeng
on behalf of the CSTAR group
CER10156
2018,36,1
Pg. 0088-0093
Free to view
An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients
L. Martínez-Estupiñán, D. Hernández-Flórez, I. Janta, J.G. Ovalles-Bonilla, J.C. Nieto, C.M. González-Fernández, T. Del Río, I. Monteagudo, F.J. López-Longo, E. Naredo, L. Valor
L. Martínez-Estupiñán, D. Hernández-Flórez, I. Janta, J.G. Ovalles-Bonilla, J.C. Nieto, C.M. González-Fernández, T. Del Río, I. Monteagudo, F.J. López-Longo, E. Naredo, L. Valor
CER10190
2018,36,1
Pg. 0094-0101
Free to view
Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis
A.S. Siebuhr, C.F. Kjelgaard-Petersen, S. Sun, I. Byrjalsen, C. Christiansen, M.A. Karsdal, A.-C. Bay-Jensen
A.S. Siebuhr, C.F. Kjelgaard-Petersen, S. Sun, I. Byrjalsen, C. Christiansen, M.A. Karsdal, A.-C. Bay-Jensen
CER10270
2018,36,1
Pg. 0102-0109
Free to view
Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study
I. Papalopoulos, A. Fanouriakis, N. Kougkas, I. Flouri, G. Sourvinos, G. Bertsias, A. Repa, N. Avgoustidis, P. Sidiropoulos
I. Papalopoulos, A. Fanouriakis, N. Kougkas, I. Flouri, G. Sourvinos, G. Bertsias, A. Repa, N. Avgoustidis, P. Sidiropoulos
CER10331
2018,36,1
Pg. 0110-0114
Free to view
Optimal concentration range of golimumab in patients with axial spondyloarthritis
A. Martínez-Feito, C. Plasencia-Rodriguez, V. Navarro-Compán, T. Jurado, E.L. Kneepkens, G.J. Wolbink, S. Martín, A. Ruiz Del Agua, R. Navarro, A. Mezcua, A. Jochems, D. Peiteado, M.G. Bonilla, A. Balsa, D. Pascual-Salcedo
A. Martínez-Feito, C. Plasencia-Rodriguez, V. Navarro-Compán, T. Jurado, E.L. Kneepkens, G.J. Wolbink, S. Martín, A. Ruiz Del Agua, R. Navarro, A. Mezcua, A. Jochems, D. Peiteado, M.G. Bonilla, A. Balsa, D. Pascual-Salcedo
CER10418
2018,36,1
Pg. 0115-0120
Free to view
Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria
A.N. Burska, J. Neilan, R.E. Chisman, R. Pitaksalee, R. Hodgett, H. Marzo-Ortega, P.G. Conaghan, R. West, P. Emery, F. Ponchel
A.N. Burska, J. Neilan, R.E. Chisman, R. Pitaksalee, R. Hodgett, H. Marzo-Ortega, P.G. Conaghan, R. West, P. Emery, F. Ponchel
CER10423
2018,36,1
Pg. 0121-0126
Free to view
Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases
O. Shovman, B. Gilburd, C. Chayat, H. Amital, P. Langevitz, A. Watad, A. Guy, D. Perez, D. Azoulay, M. Blank, Y. Segal, C. Bentow, M. Mahler, Y. Shoenfeld
O. Shovman, B. Gilburd, C. Chayat, H. Amital, P. Langevitz, A. Watad, A. Guy, D. Perez, D. Azoulay, M. Blank, Y. Segal, C. Bentow, M. Mahler, Y. Shoenfeld
CER10558
2018,36,1
Pg. 0127-0135
Free to view
A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis
F. Salaffi, M. Di Carlo, M.M. Luchetti, E. Di Donato, A. Campanati, D. Benfaremo, M. Nicolini, M. Carotti, A. Giacchetti, G. Ganzetti, L. Bugatti, A. Gabrielli, A.M. Offidani
F. Salaffi, M. Di Carlo, M.M. Luchetti, E. Di Donato, A. Campanati, D. Benfaremo, M. Nicolini, M. Carotti, A. Giacchetti, G. Ganzetti, L. Bugatti, A. Gabrielli, A.M. Offidani
Brief Papers
CER10172
2018,36,1
Pg. 0136-0139
Free to view
Improved adalimumab dose decision with comprehensive diagnostics data
M. Zänker, G. Becher, O. Arbach, M. Maurer, B. Stuhlmüller, A. Schäfer, P. Strohner, J. Brand
M. Zänker, G. Becher, O. Arbach, M. Maurer, B. Stuhlmüller, A. Schäfer, P. Strohner, J. Brand
CER10130
2018,36,1
Pg. 0140-0143
Free to view
Ex vivo inhibited cytokine profiling may explain inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis
L. Tweehuysen, K. Schraa, M.G. Netea, F.H. Van Den Hoogen, L.A. Joosten, A.A. Den Broeder
L. Tweehuysen, K. Schraa, M.G. Netea, F.H. Van Den Hoogen, L.A. Joosten, A.A. Den Broeder
Review
CER10521
2018,36,1
Pg. 0144-0152
Free to view
The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis
L. Mathsson Alm, D.L. Fountain, K.K. Cadwell, A.M. Madrigal, G. Gallo, M. Poorafshar
L. Mathsson Alm, D.L. Fountain, K.K. Cadwell, A.M. Madrigal, G. Gallo, M. Poorafshar
CER10425
2018,36,1
Pg. 0153-0162
Free to view
Vitamin D and systemic lupus erythematous: a review of immunological and clinical aspects
F. Dall'ara, M. Cutolo, L. Andreoli, A. Tincani, S. Paolino
F. Dall'ara, M. Cutolo, L. Andreoli, A. Tincani, S. Paolino
Paediatric Rheumatology
CER10228
2018,36,1
Pg. 0163-0168
Free to view
Disease activity and dropout in young persons with juvenile idiopathic arthritis in transition of care: a longitudinal observational study
P.A. Van Pelt, R.J. Dolhain, A.A. Kruize, J.J. Ammerlaan, J.W. Hazes, J.W. Bijlsma, N.M. Wulffraat
P.A. Van Pelt, R.J. Dolhain, A.A. Kruize, J.J. Ammerlaan, J.W. Hazes, J.W. Bijlsma, N.M. Wulffraat
Letters to the Editor
CER10894
2018,36,1
Pg. 0169
Free to view
The new frontier of imaging: the micron
G. Aringhieri, S. Vitali, P. Rossi, D. Caramella
G. Aringhieri, S. Vitali, P. Rossi, D. Caramella
CER10898
2018,36,1
Pg. 0170
Free to view
Reduction or cessation of antiviral agents in hepatitis B virus carriers treated with biologic agents
B. Ghang, D. Lee, I. Hwang, C.-K. Lee, B. Yoo, Y.-G. Kim
B. Ghang, D. Lee, I. Hwang, C.-K. Lee, B. Yoo, Y.-G. Kim
CER10491
2018,36,1
Pg. 0171-0172
Free to view
Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis
C.R. Holroyd, L. Parker, S. Bennett, J. Zarroug, C. Underhill, B. Davidson, R. Armstrong, N.C. Harvey, E. Dennison, C. Cooper, C.J. Edwards
C.R. Holroyd, L. Parker, S. Bennett, J. Zarroug, C. Underhill, B. Davidson, R. Armstrong, N.C. Harvey, E. Dennison, C. Cooper, C.J. Edwards
Erratum Corrige
CER11165
2018,36,1
Pg. 0172
Free to view
An overview of pathways encoding nociception
S.A. Woller, K.A. Eddinger, M. Corr, T.L. Yaksh
S.A. Woller, K.A. Eddinger, M. Corr, T.L. Yaksh
CER11166
2018,36,1
Pg. 0173
Free to view
Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice
L. Leon, L. Rodriguez-Rodriguez, D. Freites, L. Arietti, I. Morado, C. Vadillo, J.R. Lamas, B. Fernandez, J.A. Jover, L. Abasolo
L. Leon, L. Rodriguez-Rodriguez, D. Freites, L. Arietti, I. Morado, C. Vadillo, J.R. Lamas, B. Fernandez, J.A. Jover, L. Abasolo